FOR RESEARCH AND DEVELOPMENT FOR SERVICES FOR OTHERS IN THE FIELD OF BIOTECHNOLOGY AND GENETIC ENGINEERING, NAMELY, PRODUCING MONOCLONAL ANTIBODIES FOR THERAPEUTIC USES AND CELL LINES FOR PRODUCING THE SAME